46 related articles for article (PubMed ID: 3499485)
1. Revealing the genetic basis of multiple sclerosis: are we there yet?
Baranzini SE
Curr Opin Genet Dev; 2011 Jun; 21(3):317-24. PubMed ID: 21247752
[TBL] [Abstract][Full Text] [Related]
2. Population frequency of HLA haplotypes contributes to the prevalence difference of multiple sclerosis in Ireland.
McGuigan C; Dunne C; Crowley J; Hagan R; Rooney G; Lawlor E; Hutchinson M
J Neurol; 2005 Oct; 252(10):1245-8. PubMed ID: 16158194
[TBL] [Abstract][Full Text] [Related]
3. The epidemiology of multiple sclerosis in Devon: a comparison of the new and old classification criteria.
Fox CM; Bensa S; Bray I; Zajicek JP
J Neurol Neurosurg Psychiatry; 2004 Jan; 75(1):56-60. PubMed ID: 14707308
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of multiple sclerosis in south east Wales.
Swingler RJ; Compston DA
J Neurol Neurosurg Psychiatry; 1988 Dec; 51(12):1520-4. PubMed ID: 3265431
[TBL] [Abstract][Full Text] [Related]
5. Class II HLA antigens in multiple sclerosis.
Miller DH; Hornabrook RW; Dagger J; Fong R
J Neurol Neurosurg Psychiatry; 1989 May; 52(5):575-7. PubMed ID: 2732726
[TBL] [Abstract][Full Text] [Related]
6. Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities.
Olerup O; Hillert J; Fredrikson S; Olsson T; Kam-Hansen S; Möller E; Carlsson B; Wallin J
Proc Natl Acad Sci U S A; 1989 Sep; 86(18):7113-7. PubMed ID: 2571150
[TBL] [Abstract][Full Text] [Related]
7. Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental?
Miller DH; Hammond SR; McLeod JG; Purdie G; Skegg DC
J Neurol Neurosurg Psychiatry; 1990 Oct; 53(10):903-5. PubMed ID: 2266373
[TBL] [Abstract][Full Text] [Related]
8. The dissemination of multiple sclerosis. The Langdon-Brown lecture 1989.
Compston DA
J R Coll Physicians Lond; 1990 Jul; 24(3):207-18. PubMed ID: 2213676
[No Abstract] [Full Text] [Related]
9. Multiple sclerosis in the Cambridge health district of east Anglia.
Mumford CJ; Fraser MB; Wood NW; Compston DA
J Neurol Neurosurg Psychiatry; 1992 Oct; 55(10):877-82. PubMed ID: 1431950
[TBL] [Abstract][Full Text] [Related]
10. Association of HLA and multiple sclerosis.
Martin R; Vogt AB; Kropshofer H; Lichtenfels R
Behring Inst Mitt; 1994 Jul; (94):158-70. PubMed ID: 7998908
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis and functional importance of some disease-associated HLA polymorphisms.
Thorsby E; Lundin KE; Rønningen KS; Sollid LM; Vartdal F
Tissue Antigens; 1989 Jul; 34(1):39-49. PubMed ID: 2683208
[No Abstract] [Full Text] [Related]
12. HLA and multiple sclerosis in south east Wales.
Swingler RJ; Kirk PF; Darke C; Compston DA
J Neurol Neurosurg Psychiatry; 1987 Sep; 50(9):1153-5. PubMed ID: 3499485
[TBL] [Abstract][Full Text] [Related]
13. Multiple sclerosis in north-east Scotland. An association with HLA-DQw1.
Francis DA; Batchelor JR; McDonald WI; Hing SN; Dodi IA; Fielder AH; Hern JE; Downie AW
Brain; 1987 Feb; 110 ( Pt 1)():181-96. PubMed ID: 3492235
[TBL] [Abstract][Full Text] [Related]
14. HLA antigens in multiple sclerosis of northern Spanish population.
López-Larrea C; Uría DF; Coto E
J Neurol Neurosurg Psychiatry; 1990 May; 53(5):434-5. PubMed ID: 2351974
[TBL] [Abstract][Full Text] [Related]
15. HLA determinants in familial multiple sclerosis.
Grasso MG; Cutrupi F; Bernardi S; Trabace S; Pozzilli C; Cappellacci S; Fieschi C
Neuroepidemiology; 1992; 11(2):85-9. PubMed ID: 1495578
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
